Codexis (CDXS) EPS (Basic) Growth (5y) (2015 - 2026)
Codexis (CDXS) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Codexis | 150.24 Mn | 95.32 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.78% |
| Mar 31, 2026 | 7.43% |
| Dec 31, 2025 | 29.69% |
| Sep 30, 2025 | -16.07% |
| Jun 30, 2025 | -7.65% |
| Mar 31, 2025 | -14.08% |
| Dec 31, 2024 | -65.94% |
| Sep 30, 2024 | -119.27% |
| Jun 30, 2024 | -22.25% |
| Mar 31, 2024 | -11.68% |
| Dec 31, 2023 | -64.25% |
| Sep 30, 2023 | -68.41% |
| Jun 30, 2023 | -19.24% |
| Mar 31, 2023 | -28.74% |
| Dec 31, 2022 | -62.10% |
| Sep 30, 2022 | 6.38% |
| Jun 30, 2022 | 21.18% |
| Mar 31, 2022 | 6.63% |
| Dec 31, 2021 | -4.04% |
| Sep 30, 2021 | -0.22% |